• In the past week, RTX Corporation reported first-quarter 2026 results showing sales rising to US$22.08 billion and net income reaching US$2.06 billion, with both basic and diluted EPS from continuing operations increasing year on year.
• Alongside these results, RTX raised its full-year outlook on the back of double-digit organic growth and a record US$271.00 billion backlog, while continuing to invest heavily in new defense technologies such as the RAIVEN Staring EO/IR sensor suite and expanded Pratt & Whitney engine capacity.
• We’ll now examine how RTX’s raised full-year guidance and record backlog shape the company’s existing investment narrative and risk profile.

AI is about to change healthcare. These 35 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

RTX Investment Narrative Recap

To own RTX, you need to believe in its mix of defense and commercial aerospace, backed by a large, contracted revenue base and ongoing investment in technology. The latest quarter, with higher sales, earnings, and a raised outlook supported by a US$271.00 billion backlog, reinforces that thesis. In the near term, the key catalyst is execution against this backlog, while elevated and unpredictable tariff costs remain a material risk that the new results have not removed.

Among recent announcements, the successful first flight test of the RAIVEN Staring EO/IR system looks especially relevant. It sits squarely in RTX’s core defense electronics and sensing capabilities, where demand has been strong, and helps illustrate how the company is trying to deepen its product portfolio inside that record backlog rather than relying only on large missile or aircraft programs.

Yet while the backlog looks reassuring, investors should be aware that rising tariff exposure could still...

RTX's narrative projects $106.0 billion revenue and $9.9 billion earnings by 2029. This requires 6.2% yearly revenue growth and about a $3.2 billion earnings increase from $6.7 billion today.

Uncover how RTX's forecasts yield a $216.34 fair value, a 20% upside to its current price.

Exploring Other Perspectives

Four members of the Simply Wall St Community currently see RTX’s fair value between US$179.04 and US$216.34, reflecting a wide spread of expectations. Against that backdrop, the raised guidance and record backlog underline why some investors focus heavily on contract execution risk rather than short term share price moves.

Explore 4 other fair value estimates on RTX - why the stock might be worth as much as 20% more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your RTX research is our analysis highlighting 4 key rewards and 3 important warning signs that could impact your investment decision.
• Our free RTX research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate RTX's overall financial health at a glance.

Want Some Alternatives?

Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:

• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 30 best rare earth metal stocks of the very few that mine this essential strategic resource.
• The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 19 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.
• The future of work is here. Discover the 35 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.